Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid - PubMed (original) (raw)
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
D R Senger et al. Science. 1983.
Abstract
Tumor ascites fluids from guinea pigs, hamsters, and mice contain activity that rapidly increases microvascular permeability. Similar activity is also secreted by these tumor cells and a variety of other tumor cell lines in vitro. The permeability-increasing activity purified from either the culture medium or ascites fluid of one tumor, the guinea pig line 10 hepatocarcinoma, is a 34,000- to 42,000-dalton protein distinct from other known permeability factors.
Similar articles
- A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
Senger DR, Perruzzi CA, Feder J, Dvorak HF. Senger DR, et al. Cancer Res. 1986 Nov;46(11):5629-32. Cancer Res. 1986. PMID: 3756910 - Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, et al. Yeo KT, et al. Cancer Res. 1993 Jun 15;53(12):2912-8. Cancer Res. 1993. PMID: 8504432 - Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF. Nagy JA, et al. Cancer Res. 1995 Jan 15;55(2):360-8. Cancer Res. 1995. PMID: 7812969 - The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B, Aboulghar M, Smitz J, Ron-El R. Rizk B, et al. Hum Reprod Update. 1997 May-Jun;3(3):255-66. doi: 10.1093/humupd/3.3.255. Hum Reprod Update. 1997. PMID: 9322101 Review. - Paracentesis. The importance of optimal ascitic fluid analysis.
Bac DJ, Siersema PD, Wilson JH. Bac DJ, et al. Neth J Med. 1993 Oct;43(3-4):147-55. Neth J Med. 1993. PMID: 8302393 Review.
Cited by
- Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents.
Chaudhari PJ, Nemade AR, Shirkhedkar AA. Chaudhari PJ, et al. RSC Adv. 2024 Oct 22;14(45):33384-33417. doi: 10.1039/d4ra05244g. eCollection 2024 Oct 17. RSC Adv. 2024. PMID: 39439843 Free PMC article. Review. - Correlation between Periostin Expression and Pro-Angiogenic Factors in Non-Small-Cell Lung Carcinoma.
Wasik A, Podhorska-Okolow M, Dziegiel P, Piotrowska A, Kulus MJ, Kmiecik A, Ratajczak-Wielgomas K. Wasik A, et al. Cells. 2024 Aug 23;13(17):1406. doi: 10.3390/cells13171406. Cells. 2024. PMID: 39272978 Free PMC article. - Serum mRNA levels of cytokeratin-19 and vascular endothelial growth factor in oral squamous cell carcinoma and oral potentially malignant disorders using RT-PCR.
Senevirathna K, Mahakapuge TAN, Jayawardana NU, Rajapakse J, Gamage CU, Seneviratne B, Perera U, Kanmodi KK, Jayasinghe R. Senevirathna K, et al. BMC Oral Health. 2024 Sep 11;24(1):1062. doi: 10.1186/s12903-024-04834-1. BMC Oral Health. 2024. PMID: 39261828 Free PMC article. - VEGFA may be a potential marker of myopic choroidal thickness and vascular density changes.
Wan T, Shi W, Liang R, Li T, Li B, Zhou X. Wan T, et al. Sci Rep. 2024 Sep 3;14(1):20514. doi: 10.1038/s41598-024-70616-y. Sci Rep. 2024. PMID: 39227639 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources